A single-center, open-label clinical study to evaluate pharmacokinetics and pharmacodynamics of pegylated recombinant human granulocyte stimulating factor in pediatric patients with acute lymphoblastic leukemia.

Wen Yu Yang,Tian-Feng Liu,Xiao-Juan Chen,Ye Guo,Ting Li,Ben-Quan Qi,Fang Liu,Lixian Chang,Min Ruan,Xiaoming Liu,Li Zhang,Yao Zou,Yumei Chen,Xiaofan Zhu

A single-center, open-label clinical study to evaluate pharmacokinetics and pharmacodynamics of pegylated recombinant human granulocyte stimulating factor in pediatric patients with acute lymphoblastic leukemia.

2020

Wen Yu Yang
Tian-Feng Liu
Xiao-Juan Chen
Ye Guo
Ting Li
Ben-Quan Qi
Fang Liu
Lixian Chang
Min Ruan
Xiaoming Liu
Li Zhang
Yao Zou
Yumei Chen
Xiaofan Zhu

e22501Background: The aims of the study were to investigate the pharmacokinetics and pharmacodynamics of pegylated recombinant human granulocyte colony stimulating factor(PEG-rhG-CSF) in pediatric ...

Keywords:

Oncology
Single Center
Internal medicine
Granulocyte
Recombinant DNA
clinical study
Lymphoblastic Leukemia
Pathology
open label
Pharmacokinetics
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations